Shanshan Li – InmunoES

An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C–IV non-squamous NSCLC

7 de September de 2026 by Shanshan Li

BackgroundPatients with unresectable stage IIIB/C-IV non-squamous non-small cell lung cancer (NSCLC) lacking driver mutations (EGFR/ALK/ROS1/RET/BRAF/MET) face limited treatment options. This single-center prospective exploratory pilot case series, lim…

Recent advances of trace elements in autoimmune thyroid disease

26 de November de 2025 by Shanshan Li

Autoimmune thyroid disease (AITD), which includes Graves’ disease and Hashimoto’s thyroiditis, poses a substantial global health burden due to its strong environmental influences. Among environmental factors, trace elements are increasingly recognized …

Mycobacterium tuberculosis infection may increase the degrees of malignancy in lung adenocarcinoma

21 de February de 2025 by Shanshan Li

BackgroundThe early diagnosis and management of lung adenocarcinoma co-existing with tuberculosis (LAC-TB) presents significant challenges in clinical settings. This is compounded by a paucity of robust clinical evidence elucidating the interactions be…